These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle. Sys SU; Goenen MJ; Chalant CH; Brutsaert DL Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology of the bipyridines: amrinone and milrinone. Alousi AA; Johnson DC Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744 [TBL] [Abstract][Full Text] [Related]
7. Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle. Gaide MS; Kimura S; Lodge NJ; Cameron JS; Kozlovskis PL; Myerburg RJ; Bassett AL Circulation; 1986 Mar; 73(3 Pt 2):III36-45. PubMed ID: 3943180 [TBL] [Abstract][Full Text] [Related]
9. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Endoh M; Yanagisawa T; Taira N; Blinks JR Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745 [TBL] [Abstract][Full Text] [Related]
10. A report on the positive inotropic action of amrinone. Cargnelli G; Padrini R; Piovan D; Piacenza G; Ferrari M; Gallucci V Boll Soc Ital Biol Sper; 1982 Jul; 58(13):793-9. PubMed ID: 7126350 [TBL] [Abstract][Full Text] [Related]
11. Inotropic and vasodilator effects of amrinone on isolated human tissue. Wilmshurst PT; Walker JM; Fry CH; Mounsey JP; Twort CH; Williams BT; Davies MJ; Webb-Peploe MM Cardiovasc Res; 1984 May; 18(5):302-9. PubMed ID: 6733734 [TBL] [Abstract][Full Text] [Related]
12. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. Endoh M; Yamashita S; Taira N J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063 [TBL] [Abstract][Full Text] [Related]
13. Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes. Parker JC; Harper JR J Clin Invest; 1980 Aug; 66(2):254-9. PubMed ID: 7400314 [TBL] [Abstract][Full Text] [Related]
14. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment. Brown L; Erdmann E Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524 [TBL] [Abstract][Full Text] [Related]
15. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle. Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the cardiovascular activities of amrinone and AR-L57. Hayes JS; Bowling N; Boder GB; Kauffman R J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873 [TBL] [Abstract][Full Text] [Related]
18. Non-additive positive inotropic effects of amrinone and ouabain on cat papillary muscles. Brown L; Erdmann E Klin Wochenschr; 1984 May; 62(9):390-3. PubMed ID: 6727279 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of amrinone on contractility and taurine influx in rat and guinea pig hearts. Azari J; Huxtable RJ Eur J Pharmacol; 1980 Oct; 67(4):347-53. PubMed ID: 6256173 [TBL] [Abstract][Full Text] [Related]
20. Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine. Takeda K; Matsui K; Nakazawa M; Nakahara H; Imai H; Imai S Jpn J Pharmacol; 1986 Mar; 40(3):381-8. PubMed ID: 3012165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]